C1QTNF6 and nasopharyngeal carcinoma: In nasopharyngeal carcinoma, m6A-hypomethylated CTRP6 drives radio resistance by stabilizing MAMs and inhibiting ferroptosis through the CTRP6–GRP78 axis [52], highlighting its role in therapy evasion.